Document is current
Any future updates will be listed below
-
Authors
Arutyunyan, Anna http://orcid.org/0000-0003-0453-5443
Roberts, Kenny http://orcid.org/0000-0001-6155-0821
Troulé, Kevin
Wong, Frederick C. K.
Sheridan, Megan A. http://orcid.org/0000-0002-6878-7976
Kats, Ilia http://orcid.org/0000-0001-5220-5671
Garcia-Alonso, Luz
Velten, Britta
Hoo, Regina
Ruiz-Morales, Elias R. http://orcid.org/0000-0002-5801-6190
Sancho-Serra, Carmen
Shilts, Jarrod
Handfield, Louis-Francois
Marconato, Luca http://orcid.org/0000-0003-3198-1326
Tuck, Elizabeth
Gardner, Lucy http://orcid.org/0000-0003-1735-2005
Mazzeo, Cecilia Icoresi
Li, Qian
Kelava, Iva
Wright, Gavin J. http://orcid.org/0000-0003-0537-0863
Prigmore, Elena http://orcid.org/0000-0001-8870-0316
Teichmann, Sarah A. http://orcid.org/0000-0002-6294-6366
Bayraktar, Omer Ali http://orcid.org/0000-0001-6055-277X
Moffett, Ashley http://orcid.org/0000-0002-8388-9073
Stegle, Oliver http://orcid.org/0000-0002-8818-7193
Turco, Margherita Y. http://orcid.org/0000-0002-3380-7375
Vento-Tormo, Roser http://orcid.org/0000-0002-9870-8474
- License Information
-
More Information
Article History
Received: 30 May 2022
Accepted: 21 February 2023
First Online: 29 March 2023
Competing interests
: S.A.T. has received remuneration for consulting and scientific advisory board work from Genentech, Biogen, Roche and GlaxoSmithKline as well as Foresite Labs over the past three years. O.S. is a paid scientific advisory board member of Insitro Inc.
